5.00-5.05 Spontaneous normal tension glaucoma in aged marmosets Takayuki Harada (Japan)
5.05-5.10 Bimatoprost Sustained-Release Implant for Lowering Intraocular Pressure: Long-Term Efficacy and Patient-Reported Outcomes Randy au
Craven (United States)
5.10-5.15 Efficacy of A Deep Learning System for Detecting Glaucomatous Optic Neuropathy based on Color Fundus Photographs Mingguang He (China)
5.15-5.20 In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis Cynthia Yu-Wai-Man (United Kingdom)
5.20-5.25 Combined Optical Coherence Tomography and Visual Field Endpoints to Improve Future Glaucoma Clinical Trials Zhichao Wu (Australia)
5.25-5.30 Progression in Perimetrically Normal Eyes of Open-angle Glaucoma Patients with Unilateral Visual Field Loss: An Eight-year-follow-up Study Xiang Fan (China)
5.30-5.35 Interim results of a prospective, randomized phase 2 study evaluating the safety and efficacy of Travoprost Intraocular Implants Robert Edward Ang (Philippines)
5.35-5.40 Development and Validation of a Deep Learning Classifier to Detect Gonioscopic Angle Closure Based on Anterior Segment OCT Images Benjamin Xu (United States)
5.40-5.45 Wound healing and its potential biomarkers in human tear after trabeculectomy Natalia Volkova (Russian Federation)
5.00-5.05 XEN Gel Stent Surgery in Patients with Open Angle Glaucoma: Two-Year Results Alice Di Domenico (Italy)
5.05-5.10 Outcomes of combined trabeculotomy with trabeculectomy in children with Aniridia and secondary glaucoma. Nkechinyere Judith Uche (India)
5.10-5.15 Trabecular Micro-Bypass with Cataract Surgery for Patients with Glaucoma: A Systematic Review and Meta-Analysis Nathan Kerr (Australia)
5.15-5.20 Comparison of bleb morphology by conjunctival incision after trabeculectomy Hailong Huang (Japan)
5.20-5.25 Multicenter, randomized study of a Schlemmâs canal microstent for reduction of IOP in primary open angle glaucoma (The HORIZON Trial) Cathleen McCabe (United States)
5.25-5.30 Real World MIGS: Australian & New Zealand experience of > 1000 Hydrus Microstent implants with 1 to 3 year follow up. Ashish Agar (Australia)
5.30-5.35 Post-operative outcomes of revision surgery for failed XEN Implants at a UK tertiary eye centre Emma Linton (United Kingdom)
5.35-5.40 Ab interno gel implant for the treatment of refractory glaucoma: results from the International Glaucoma Surgery Registry (IGSR) Nathan Kerr (Australia)
5.40-5.45 Lens Extraction with or without Goniosynechialysis in Primary Angle Closure Disease for angle parameters assessment. Jyoti Shakrawal (India)
5.45-5.50 Risk factors for corneal endothelial cell loss after trabeculectomy with mitomycin C Tomomi Higashide (Japan)
5.50-5.55 Goniowash: a new surgical approach combined with cataract surgery to lower intraocular pressure in pseudoexfoliation syndrome. Van Tao Tran (Switzerland)
